Close Menu

NEW YORK – A study evaluating the efficacy of molecular tumor board recommendations at the University Medical Center Groningen found that lung cancer patients' treating doctors were willing to take up the expert body's targeted therapy recommendations, and when they did, these treatments shrunk tumors in two-thirds of patients. 

The results of the retrospective analysis were published last week in JCO Precision Oncology

To read the full story....

...and receive Weekly News bulletins.

Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.

Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.

Dec
02
Sponsored by
Qiagen

The Phosphoinositide 3-Kinase (PI3K) pathway is one of the most frequently altered pathways in human cancer and plays a significant role in disease progression and resistance to endocrine therapy.